Proponents of psychedelic drugs are advocating for approval to help treat mental health conditions. Health Secretary Robert F. Kennedy Jr. has indicated a timeline of 12 months for making psychedelic therapy available, a move that is surprising to many supporters. Despite enthusiasm, there is concern about rushing the approval process and its association with Kennedy’s controversial reputation. The FDA recently rejected MDMA for PTSD treatments but is now reconsidering the drug, labeling it as a priority. Advocates like Rick Doblin have long pushed for the medical use of MDMA, remaining cautiously optimistic about future developments, especially in traditionally conservative states.
Robert F. Kennedy Jr. emphasized that the therapeutic use of psychedelics presents tremendous advantages when administered within proper clinical settings, and efforts are underway to facilitate this within 12 months.
Rick Doblin expressed cautious optimism regarding the potential approval of MDMA for medical use, while voicing concerns that public perception could be negatively influenced due to RFK's controversial background.
The FDA initially rejected MDMA for PTSD treatment due to flawed data but is now prepared to revisit the evaluation, signaling a shift in regulatory approach.
Support for psychedelics extends into conservative areas, as seen with figures like Rick Perry advocating for their medical use, despite ongoing debates about safety and efficacy.
Collection
[
|
...
]